Nextech Invest Ltd.

CIK 0001595430 · ZURICH, null · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Nextech Invest Ltd. reported 15 positions worth $2.11B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: RVMD (67.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$2.11B
2026 Q2
Positions
15
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
98.0%
Est. Net Flow (Q)
2026 Q2
10 / 15 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1RVMD REVOLUTION MEDICINES INC SH$1.42B67.55%7,601,087
2PBLS PARABILIS MEDICINES INC SH$127.6M6.06%4,663,176
3RLAY RELAY THERAPEUTICS INC SH$126.8M6.02%6,776,506
4TYRA TYRA BIOSCIENCES INC SH$113.5M5.39%3,553,585
5ALMS ALUMIS INC SH$99.6M4.73%3,540,998
6ORIC ORIC PHARMACEUTICALS INC SH$77.6M3.68%7,162,637
7KYMR KYMERA THERAPEUTICS INC SH$32.0M1.52%278,896
8ZYME ZYMEWORKS INC SH$29.1M1.38%1,113,946
9GLUE MONTE ROSA THERAPEUTICS INC SH$18.4M0.87%761,153
10ARVN ARVINAS INC SH$17.1M0.81%1,122,713

The free plan shows the top 10 positions. The remaining 5 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Nextech Invest Ltd. hold as of Q2 2026?

Nextech Invest Ltd. reported 15 positions worth $2.11B in its Q2 2026 13F filing. Largest positions: RVMD (67.6%), PBLS (6.1%), RLAY (6.0%), TYRA (5.4%) and ALMS (4.7%).

What did Nextech Invest Ltd. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Nextech Invest Ltd. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.